Moxonidine Teva (Moxonidine)

Moxonidine acts as a selective agonist at central imidazoline I1 receptors. Activation of these receptors diminishes sympathetic nervous system activity, leading to reduced peripheral vascular resistance and a subsequent fall in arterial blood pressure.

The dosage of Moxonidine is individualized by the prescribing clinician based on the patient’s blood pressure, response, and tolerability. The prescriber determines the appropriate starting dose and any subsequent adjustments.

The pregnancy category for Moxonidine is not clearly established. It should only be used during pregnancy or lactation if the potential benefit justifies the possible risk to the fetus or infant, and after a careful risk‑benefit assessment by the healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moxonidine differs from agents such as clonidine by selectively targeting imidazoline I1 receptors rather than alpha‑2 adrenergic receptors. This selectivity may result in a lower incidence of certain side effects like sedation, while still providing effective blood‑pressure reduction.

Moxonidine tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children.

Moxonidine is taken orally, usually with or without food, as directed by the prescribing physician. The tablets should be swallowed whole with a glass of water and not chewed or crushed.

Serious adverse events include severe hypotension, bradycardia, allergic reactions such as rash or swelling, liver enzyme abnormalities, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience any of these symptoms.

Moxonidine is contraindicated in patients with known hypersensitivity to the drug, severe hepatic impairment, or those who have experienced a marked drop in blood pressure with prior use. Caution is also advised for individuals with significant cardiac conduction disorders.